The Delhi High Court on Tuesday granted interim stay to Abbott’s India unit, and domestic companies Glenmark Pharma and Macleods Pharma, on the prohibition on sale of several combination drugs.
The Delhi High Court on Tuesday granted interim stay to Abbott’s India unit, and domestic companies Glenmark Pharma and Macleods Pharma, on the prohibition on sale of several combination drugs.
India banned 344 drug combinations over the weekend, including Abbott’s codeine-based cough syrup, after a government panel of experts found they had “no therapeutic justification.”
The judge granted an interim stay to the pharmaceutical companies and said regulators should take “no coercive steps” against them.
Next Story